THE MMDP PROJECT
The Morbidity Management and Disability Prevention (MMDP) Project is a five-year, $35 million global project funded by the U.S. Agency for International Development (USAID). The project helps countries provide high-quality treatment and care for people suffering from the debilitating effects of trachoma and lymphatic filariasis, complementing other major initiatives supporting disease elimination through mass drug administration. With activities in Ethiopia, Cameroon and Burkina Faso and in the global community, the MMDP Project is a key player in the global push to eliminate trachoma and lymphatic filariasis as public health problems by 2020.
The MMDP Project is led by Helen Keller International in partnership with RTI International. The project spans from July 22, 2014, through July 21, 2019.
To treat trichiasis, the painful, blinding stage of trachoma, the MMDP Project is working to provide sight-preserving eyelid surgery. When individuals decline surgery, we support countries in their decision to offer counseling on proper techniques for eyelash epilation.
For lymphatic filariasis, the project seeks to surgically treat men with hydrocele, the disabling and stigmatizing condition in which the scrotum becomes severely swollen. The project also helps individuals with badly swollen limbs -- and the family members who care for them -- learn effective ways to manage lymphedema and prevent recurring bouts of inflammation.